Literature DB >> 2465715

Acute pancreatitis due to 5-aminosalicylate.

B Sachedina1, F Saibil, L B Cohen, J Whittey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2465715     DOI： 10.7326/0003-4819-110-6-490

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  15 in total

1.  Lack of evidence for fibrosing colonopathy by 5-ASA in humans.

Authors:  M L Borum; A L Ginsberg
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

2.  Acute pancreatitis during oral 5-aminosalicylic acid therapy.

Authors:  M T Fiorentini; M Fracchia; G Galatola; A Barlotta; M de la Pierre
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

Review 3.  Acute pancreatitis secondary to 5-aminosalicylic acid therapy in a patient with ulcerative colitis.

Authors:  E Adachi; K Okazaki; Y Matsushima; H Seno; K Uchida; H Nakase; C Kawanami; T Nakamura; T Chiba
Journal:  Int J Pancreatol       Date:  1999-06

Review 4.  Hypersensitivity to 5-ASA suppositories.

Authors:  M L Borum; A Ginsberg
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

Review 5.  Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.

Authors:  S B Hanauer; G Stathopoulos
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

6.  Evaluation of the physicochemical properties and dissolution characteristics of mesalamine: relevance to controlled intestinal drug delivery.

Authors:  D L French; J W Mauger
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

7.  Acute pancreatitis complicating Crohn's disease: mere coincidence or causality?

Authors:  A Tromm; D Hüppe; G H Micklefield; U Schwegler; B May
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

8.  Comparison of anti-inflammatory mechanisms of mango (Mangifera Indica L.) and pomegranate (Punica Granatum L.) in a preclinical model of colitis.

Authors:  Hyemee Kim; Nivedita Banerjee; Ivan Ivanov; Catherine M Pfent; Kalan R Prudhomme; William H Bisson; Roderick H Dashwood; Stephen T Talcott; Susanne U Mertens-Talcott
Journal:  Mol Nutr Food Res       Date:  2016-05-23       Impact factor: 5.914

Review 9.  Comparative tolerability of therapies for ulcerative colitis.

Authors:  Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  Prooxidant properties of 5-aminosalicylic acid. Possible mechanism for its adverse side effects.

Authors:  M B Grisham; K Ware; S Marshall; T Yamada; I S Sandhu
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.